-
1
-
-
0029782485
-
Carrier-mediated intestinal transport of drugs
-
1. A. Tsuji and I. Tamai. Carrier-mediated intestinal transport of drugs. Pharm. Res. 13:963-977 (1996).
-
(1996)
Pharm. Res.
, vol.13
, pp. 963-977
-
-
Tsuji, A.1
Tamai, I.2
-
2
-
-
0025057187
-
Metabolism of drugs and other xenobiotics in the gut lumen and wall
-
2. K. F. Ilett, L. B. Tee, P. T. Reeves, and R. F. Minchin. Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacol. Ther. 46:67-93 (1990).
-
(1990)
Pharmacol. Ther.
, vol.46
, pp. 67-93
-
-
Ilett, K.F.1
Tee, L.B.2
Reeves, P.T.3
Minchin, R.F.4
-
3
-
-
0023833285
-
Localization and characterization of drug-metabolizing enzymes along the villus-crypt surface of the rat small intestine I. Monooxyenases
-
3. R. K. Dubey and J. Singh. Localization and characterization of drug-metabolizing enzymes along the villus-crypt surface of the rat small intestine I. Monooxyenases Biochem. Pharmacol. 37:169-176 (1988).
-
(1988)
Biochem. Pharmacol.
, vol.37
, pp. 169-176
-
-
Dubey, R.K.1
Singh, J.2
-
4
-
-
0023858626
-
Localization and characterization of drug-metabolizing enzymes along the villus-crypt surface of the rat small intestine II. Conjugases
-
4. R. K. Dubey and J. Singh. Localization and characterization of drug-metabolizing enzymes along the villus-crypt surface of the rat small intestine II. Conjugases Biochem. Pharmacol. 37: 177-184 (1988).
-
(1988)
Biochem. Pharmacol.
, vol.37
, pp. 177-184
-
-
Dubey, R.K.1
Singh, J.2
-
5
-
-
0023588109
-
Identification of glucocorticoid-inducible cytochrome P-450 in the intestinal mucosa of rats and man
-
5. P. B. Watkins, S. A. Wrighton, E. G. Schuetz, D. T. Molowa, and P. S. Guzelian. Identification of glucocorticoid-inducible cytochrome P-450 in the intestinal mucosa of rats and man. J. Clin. Invest. 80:1029-1036 (1987).
-
(1987)
J. Clin. Invest.
, vol.80
, pp. 1029-1036
-
-
Watkins, P.B.1
Wrighton, S.A.2
Schuetz, E.G.3
Molowa, D.T.4
Guzelian, P.S.5
-
6
-
-
0029738490
-
First-pass metabolism of midazolam by the human intestine
-
6. M. F. Paine, D. D. Shen, K. L. Kunze, J. D. Perkins, C. L. Marsh, J. P. McVicar, D. M. Barr, B. S. Gilles, and K. E. Thummel. First-pass metabolism of midazolam by the human intestine. Clin. Pharmacol. Ther. 60:14-24 (1996).
-
(1996)
Clin. Pharmacol. Ther.
, vol.60
, pp. 14-24
-
-
Paine, M.F.1
Shen, D.D.2
Kunze, K.L.3
Perkins, J.D.4
Marsh, C.L.5
McVicar, J.P.6
Barr, D.M.7
Gilles, B.S.8
Thummel, K.E.9
-
7
-
-
0031445547
-
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism
-
7. M. F. Paine, M. Khalighi, J. M. Fisher, D. D. Shen, K. L. Kunze, C. L. Marsh, J. D. Perkins, and K. E. Thummel. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J. Pharmacol. Exp. Ther. 283:1552-1562 (1997).
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.283
, pp. 1552-1562
-
-
Paine, M.F.1
Khalighi, M.2
Fisher, J.M.3
Shen, D.D.4
Kunze, K.L.5
Marsh, C.L.6
Perkins, J.D.7
Thummel, K.E.8
-
8
-
-
0028820208
-
Differentiation of absorption and first-pass gut metabolism in humans: Studies with cyclosporine
-
8. C.-Y. Wu, L. Z. Benet, M. F. Herbert, S. K. Gupta. M. Rowland, D. Y. Gomez, and V. J. Wacher. Differentiation of absorption and first-pass gut metabolism in humans: studies with cyclosporine. Clin. Pharmacol. Ther. 58:492-497 (1995).
-
(1995)
Clin. Pharmacol. Ther.
, vol.58
, pp. 492-497
-
-
Wu, C.-Y.1
Benet, L.Z.2
Herbert, M.F.3
Gupta, S.K.4
Rowland, M.5
Gomez, D.Y.6
Wacher, V.J.7
-
9
-
-
0031863355
-
Metabolism and transport of the macrolide sirolimus in the small intestine
-
9. A. Lampen, Y. Zhang, I. Hackbarth, L. Z. Benet, K. -Fr. Sewing, and U. Christians. Metabolism and transport of the macrolide sirolimus in the small intestine. J. Pharmacol. Exp. Ther. 285:1104-1112 (1998).
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.285
, pp. 1104-1112
-
-
Lampen, A.1
Zhang, Y.2
Hackbarth, I.3
Benet, L.Z.4
Sewing, K.-F.5
Christians, U.6
-
10
-
-
0028840847
-
Possible involvement of multiple P-glycoprotein mediated efflux systems in the transport of verapamil and other organic cations across rat intestine
-
10. H. Saitoh and B. J. Aungst. Possible involvement of multiple P-glycoprotein mediated efflux systems in the transport of verapamil and other organic cations across rat intestine. Pharm. Res. 12:1304-1310 (1995).
-
(1995)
Pharm. Res.
, vol.12
, pp. 1304-1310
-
-
Saitoh, H.1
Aungst, B.J.2
-
11
-
-
12644272784
-
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
-
11. K. S. Lown, R. R. Mayo, A. B. Leichtman, H.-L. Hsiao, K. Turgeon, P. Schmiedin-Ren, M. B. Brown, W. Guo, S. J. Rossi, L. Z. Benet, and P. B. Watkins. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin. Pharmacol. Ther. 62:48-60 (1997).
-
(1997)
Clin. Pharmacol. Ther.
, vol.62
, pp. 48-60
-
-
Lown, K.S.1
Mayo, R.R.2
Leichtman, A.B.3
Hsiao, H.-L.4
Turgeon, K.5
Schmiedin-Ren, P.6
Brown, M.B.7
Guo, W.8
Rossi, S.J.9
Benet, L.Z.10
Watkins, P.B.11
-
12
-
-
0031921312
-
Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption
-
12. J. W. Smit, A. H. Schinkel, M. Müller, B. Weert, and D. K. F. Meijer. Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption. Hepatology 27:1056-1063 (1998).
-
(1998)
Hepatology
, vol.27
, pp. 1056-1063
-
-
Smit, J.W.1
Schinkel, A.H.2
Müller, M.3
Weert, B.4
Meijer, D.K.F.5
-
13
-
-
0031416567
-
The role of the intestine in the absorption and metabolism of drugs
-
13. M. Doherty and K. S. Pang. The role of the intestine in the absorption and metabolism of drugs. Drug Chem. Toxicol. 20:329-344 (1997).
-
(1997)
Drug Chem. Toxicol.
, vol.20
, pp. 329-344
-
-
Doherty, M.1
Pang, K.S.2
-
14
-
-
0031765907
-
Role of P-glycoprotein and cytochrome P450 3a in limiting oral absorption of peptides and peptidomimetics
-
14. V. J. Wacher, J. A. Silverman, Y. Zhang, and L. Z. Benet. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J. Pharm. Sci. 87:1322-1330 (1998).
-
(1998)
J. Pharm. Sci.
, vol.87
, pp. 1322-1330
-
-
Wacher, V.J.1
Silverman, J.A.2
Zhang, Y.3
Benet, L.Z.4
-
15
-
-
0032949332
-
Symposium article. Molecular and physical mechanisms of first-pass extraction
-
15. S. D. Hall, K. E. Thummel, P. B. Watkins, K. S. Lown, L. Z. Benet, M. F. Paine, R. R. Mayo, D. K. Turgeon, D. G. Bailey, R. J. Fontana, and S. A. Wrighton. Symposium Article. Molecular and physical mechanisms of first-pass extraction. Drug Metab. Dispos. 27:161-166 (1999).
-
(1999)
Drug Metab. Dispos.
, vol.27
, pp. 161-166
-
-
Hall, S.D.1
Thummel, K.E.2
Watkins, P.B.3
Lown, K.S.4
Benet, L.Z.5
Paine, M.F.6
Mayo, R.R.7
Turgeon, D.K.8
Bailey, D.G.9
Fontana, R.J.10
Wrighton, S.A.11
-
16
-
-
0033009998
-
Is the role of the small intestine in first-pass metabolism overemphasized?
-
16. J. H. Lin, M. Chiba, and T. A. Baillie. Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol. Rev. 51:135-158 (1999).
-
(1999)
Pharmacol. Rev.
, vol.51
, pp. 135-158
-
-
Lin, J.H.1
Chiba, M.2
Baillie, T.A.3
-
17
-
-
0022263297
-
Disposition of enalapril in the perfused rat intestine-liver preparation: Absorption, metabolism and first pass effect
-
17. K. S. Pang, W. F. Cherry, and E. H. Ulm. Disposition of enalapril in the perfused rat intestine-liver preparation: Absorption, metabolism and first pass effect. J. Pharmacol. Exp. Ther. 233:788-795 (1985).
-
(1985)
J. Pharmacol. Exp. Ther.
, vol.233
, pp. 788-795
-
-
Pang, K.S.1
Cherry, W.F.2
Ulm, E.H.3
-
18
-
-
0022596263
-
Absorption and metabolism of acetaminophen by the in situ perfused rat small intestine preparation
-
18. K. S. Pang, S. Fayz, V. Yuen, J. te Koppele, and G. J. Mulder. Absorption and metabolism of acetaminophen by the in situ perfused rat small intestine preparation. Drug Metab. Dispos. 14:102-113 (1986).
-
(1986)
Drug Metab. Dispos.
, vol.14
, pp. 102-113
-
-
Pang, K.S.1
Fayz, S.2
Yuen, V.3
Te Koppele, J.4
Mulder, G.J.5
-
19
-
-
0013588695
-
-
Abstract, ASPET Meeting, San Diego
-
19. M. M. Doherty, K. Poon, and K. S. Pang. Morphine disposition in the vascularly perfused in situ rat intestine preparation. Abstract, ASPET Meeting, San Diego, (1997).
-
(1997)
Morphine Disposition in the Vascularly Perfused in Situ Rat Intestine Preparation
-
-
Doherty, M.M.1
Poon, K.2
Pang, K.S.3
-
20
-
-
0032969265
-
First-pass disposition of (-)-6-aminocarbovir in rats. I. Prodrug activation may be limited by access to enzyme
-
20. Y. Wen, R. P. Remmel, and C. L. Zimmerman. First-pass disposition of (-)-6-aminocarbovir in rats. I. Prodrug activation may be limited by access to enzyme. Drug Metab. Dispos. 27: 113-121 (1999).
-
(1999)
Drug Metab. Dispos.
, vol.27
, pp. 113-121
-
-
Wen, Y.1
Remmel, R.P.2
Zimmerman, C.L.3
-
21
-
-
0028113492
-
Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test
-
21. K. S. Lown, J. C. Kolars, K. E. Thummel, J. L. Barnett, K. L. Kunze, S. A. Wrighton, and P. B. Watkins. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test. Drug Metab. Dispos. 22:947-955 (1994).
-
(1994)
Drug Metab. Dispos.
, vol.22
, pp. 947-955
-
-
Lown, K.S.1
Kolars, J.C.2
Thummel, K.E.3
Barnett, J.L.4
Kunze, K.L.5
Wrighton, S.A.6
Watkins, P.B.7
-
22
-
-
0024556650
-
Erythromycin breath test as an assay of glucuocorticoid-inducible liver cytochrome P-450
-
22. P. B. Watkins, S. A. Murray, L. G. Winkelman D. M. Heuman, S. A. Wrighton, and P. S. Guzelian. Erythromycin breath test as an assay of glucuocorticoid-inducible liver cytochrome P-450. J. Clin. Invest. 83:688-697 (1989).
-
(1989)
J. Clin. Invest.
, vol.83
, pp. 688-697
-
-
Watkins, P.B.1
Murray, S.A.2
Winkelman, L.G.3
Heuman, D.M.4
Wrighton, S.A.5
Guzelian, P.S.6
-
23
-
-
0016331730
-
Morphine metabolism II. Studies on morphine glucuronyltransferase activity in intestinal microsomes of rats
-
23. E. del Villar, E. Sanchez, and T. R. Tephly. Morphine metabolism II. Studies on morphine glucuronyltransferase activity in intestinal microsomes of rats. Drug. Metab. Dispos. 2:370-374 (1974).
-
(1974)
Drug. Metab. Dispos.
, vol.2
, pp. 370-374
-
-
Del Villar, E.1
Sanchez, E.2
Tephly, T.R.3
-
24
-
-
0020618691
-
Glucuronidation in isolated perfused rat intestinal segments after mucosal and serosal administration of I-naphthol
-
24. A. S. Koster and J. Noordhoek. Glucuronidation in isolated perfused rat intestinal segments after mucosal and serosal administration of I-naphthol. J. Pharmacol Exp. Ther. 226:553-538 (1983).
-
(1983)
J. Pharmacol Exp. Ther.
, vol.226
, pp. 553-1538
-
-
Koster, A.S.1
Noordhoek, J.2
-
25
-
-
0027221177
-
Synthetic and natural opiates interact with P-glycoprotein in multidrug resistant cells
-
25. R. Callaghan and J. R. Riordan. Synthetic and natural opiates interact with P-glycoprotein in multidrug resistant cells. J. Biol. Chem. 268:16059-16064 (1993).
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 16059-16064
-
-
Callaghan, R.1
Riordan, J.R.2
-
26
-
-
0028825399
-
Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin
-
26. A. H. Schinkel, E. Wagenaar, L. Van Deemter, C. A. A. M. Mol, and P. Borst. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96:1968-1705 (1995).
-
(1995)
A. J. Clin. Invest.
, vol.96
, pp. 1968-11705
-
-
Schinkel, A.H.1
Wagenaar, E.2
Van Deemter, L.3
Mol, C.A.A.M.4
Borst, P.5
-
27
-
-
0019430432
-
Overcoming the vincristine resistance in p833 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
-
27. T. Tsuruo, H. Tida, S. Sukagashi, and Y. Sakurai. Overcoming the vincristine resistance in P833 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41:1967-1972 (1991).
-
(1991)
Cancer Res.
, vol.41
, pp. 1967-1972
-
-
Tsuruo, T.1
Tida, H.2
Sukagashi, S.3
Sakurai, Y.4
-
29
-
-
0020309039
-
Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography
-
29. O. Svensson, A. Rane, J. Sawe, and F. Sjoqvist. Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. J. Chromatogr. 230:427-432 (1982).
-
(1982)
J. Chromatogr.
, vol.230
, pp. 427-432
-
-
Svensson, O.1
Rane, A.2
Sawe, J.3
Sjoqvist, F.4
-
30
-
-
0017685973
-
Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat
-
30. L. I. Harrison, and M. Gibaldi. Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat. J. Pharm. Sci. 66:1138-1142 (1977).
-
(1977)
J. Pharm. Sci.
, vol.66
, pp. 1138-1142
-
-
Harrison, L.I.1
Gibaldi, M.2
-
31
-
-
0027278725
-
Extent and implications of interspecies differences in the intestinal hydrolysis of certain glucuronide conjugates
-
31. E. M. Kenyon and E. J. Calabrese. Extent and implications of interspecies differences in the intestinal hydrolysis of certain glucuronide conjugates. Xenobiotica 23:373-381 (1993).
-
(1993)
Xenobiotica
, vol.23
, pp. 373-381
-
-
Kenyon, E.M.1
Calabrese, E.J.2
-
32
-
-
0000697460
-
Viability of the vascularly perfused, recalculating rat intestine and intestine-liver preparations
-
32. H. Hirayama, X. Xu, and K. S. Pang. Viability of the vascularly perfused, recalculating rat intestine and intestine-liver preparations. Am. J. Physiol. 89:G249-G258 (1989).
-
(1989)
Am. J. Physiol.
, vol.89
, pp. G249-G258
-
-
Hirayama, H.1
Xu, X.2
Pang, K.S.3
-
33
-
-
0023488459
-
Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine
-
33. M. Mistry and J. B. Houston. Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine. Drug. Metab. Dispos. 15:710-717 (1987).
-
(1987)
Drug. Metab. Dispos.
, vol.15
, pp. 710-717
-
-
Mistry, M.1
Houston, J.B.2
-
34
-
-
0021915994
-
Glucuronidation of morphine and six β2-sympathominetics in isolated rat intestinal epithelial cells
-
34. A. S. Koster, A. C. Frankhuijzen-Sierevogel, and J. Noordhoek. Glucuronidation of morphine and six β2-sympathominetics in isolated rat intestinal epithelial cells. Drug. Metab. Dispos. 13:232-237 (1985).
-
(1985)
Drug. Metab. Dispos.
, vol.13
, pp. 232-237
-
-
Koster, A.S.1
Frankhuijzen-Sierevogel, A.C.2
Noordhoek, J.3
-
35
-
-
0033984905
-
A new, physiologically-based segregated-flow model to explain route-dependent intestinal metabolism
-
35. D. Cong, M. Doherty, and K. S. Pang. A new, physiologically-based segregated-flow model to explain route-dependent intestinal metabolism. Drug Metab. Dispos. 28:224-235 (2000).
-
(2000)
Drug Metab. Dispos.
, vol.28
, pp. 224-235
-
-
Cong, D.1
Doherty, M.2
Pang, K.S.3
-
36
-
-
0016818880
-
Studies of the enterohepatic circulation of morphine in the rat
-
36. C. T. Walsh and R. E. Levine. Studies of the enterohepatic circulation of morphine in the rat. J. Pharmacol. Exp. Ther. 195:303-310 (1975).
-
(1975)
J. Pharmacol. Exp. Ther.
, vol.195
, pp. 303-310
-
-
Walsh, C.T.1
Levine, R.E.2
-
38
-
-
0032798013
-
P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells
-
38. S. P. Letrent, J. W. Polli, J. E. Humphreys, G. M. Pollack, K. R. Brouwer, and K.L.R. Brouwer. P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells. Biochem. Pharmacol. 58:951-957 (1999).
-
(1999)
Biochem. Pharmacol.
, vol.58
, pp. 951-957
-
-
Letrent, S.P.1
Polli, J.W.2
Humphreys, J.E.3
Pollack, G.M.4
Brouwer, K.R.5
Brouwer, K.L.R.6
-
39
-
-
0031946026
-
Effect of GF 120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat
-
39. S. P. Letrent, G. M. Pollack, K. R. Brouwer, and K. L. R. Brouwer. Effect of GF 120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat. Pharm. Res. 15:599-605 (1998).
-
(1998)
Pharm. Res.
, vol.15
, pp. 599-605
-
-
Letrent, S.P.1
Pollack, G.M.2
Brouwer, K.R.3
Brouwer, K.L.R.4
-
40
-
-
0026747078
-
3′-Azido-3′-deoxythymidine drug interactions
-
40. J. F. Rajaonarison, B. Lacrelle, J. Catalin, M. Placidi, and R. Rahmani. 3′-Azido-3′-deoxythymidine drug interactions. Drug. Metab. Dispos. 20:578-584 (1992).
-
(1992)
Drug. Metab. Dispos.
, vol.20
, pp. 578-584
-
-
Rajaonarison, J.F.1
Lacrelle, B.2
Catalin, J.3
Placidi, M.4
Rahmani, R.5
|